• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Kids v Cancer

A PEDIATRIC CANCER THINK TANK

DONATE
  • GIVE KIDS A CHANCE act
  • RACE for Children Act
  • Creating Hope Act Pediatric Vouchers
  • CLIMB THE HILL
    • What is Climb the Hill Day?
    • Climb the Hill Youth Advocacy Day Sign Up
    • Video and photo gallery
    • (video) Climb the Hill Youth Advocacy Day — Why Do We Do It?
  • Compassionate Use Navigator
    • Information for Families
    • Information for Physicians
  • Who We Are
    • About Us
    • Mission and Impact
    • Contact
  • News & publications
    • Kids v Cancer in the News
    • Kids v Cancer Publications

(Washington Post) Reauthorize the Creating Hope Act to help kids with rare diseases

September 25, 2020

LETTER TO THE EDITOR

Regarding Theresa Vargas’s Sept. 20 Metro column, “New hope for kids with rare tumors”:

It takes enormous courage for a child to live with a rare disease, and tremendous strength to be a parent of a child with a disease that has no cure. Families of children with cancer, genetic conditions and other rare diseases wake up each morning hoping for a scientific breakthrough. Especially now, when science is under attack, any new treatment should be celebrated.

The inspirational story of 10-year-old Autumn Schierling’s fight with neurofibromatosis and the successful development of selumetinib for her condition offer a timely example of how a law can help children with rare diseases. The Creating Hope Act, passed in 2012, encourages companies to develop drugs for children such as Autumn by awarding a priority review voucher when a new drug for a rare pediatric disease is approved. Selumetinib and 23 drugs for cancer, Duchenne muscular dystrophy, cystic fibrosis and other rare diseases have been approved and earned vouchers under the Creating Hope Act. The industry’s interest in creating drugs for rare pediatric diseases, almost nonexistent eight years ago, has been growing exponentially — more than 65 drugs for rare diseases that affect children are in the pipeline now.

But the Creating Hope Act is expiring at the end of September. Permanent reauthorization of this law is needed so more children can wake up with hope.

Elena Gerasimov, Washington

The writer is programs director for Kids v Cancer.

The Washington Post, September 25, 2020

  • We are in the news
  • Our Publications
  • Our Op-Eds & Speeches
  • Legislation / Proclamations
  • Videos / Photos
  • RELEVANT NEWS
    • RACE for Children Act
    • Creating Hope Act/ Pediatric vouchers
    • Compassionate Use
    • Kids’ Eligibility for Trials
  • Facebook
  • Twitter

DONATE SUBSCRIBE

Kids v Cancer · 3602 Newark Street NW · Washington D.C. 20016 · 646-361-3590 · contact

© 2023 Kids v Cancer All Rights Reserved a 501(c)(3) nonprofit organization EIN 27-1427784 Privacy Policy Terms of Use Sitemap